Previous Article | Next Article ![]()
Infect Immun, July 1998, p. 3295-3302, Vol. 66, No. 7
Department of Medicine,
Received 19 September 1997/Returned for modification 3 December
1997/Accepted 15 April 1998
Toxoplasma gondii is a well-described ubiquitous
Apicomplexan protozoan parasite that is an important opportunistic
pathogen. The factors affecting the transition of tachyzoites to the
latent bradyzoite stage remain to be defined. The induction of
bradyzoite development in vitro has been linked to temperature, pH,
mitochondrial inhibitors, sodium arsenite, and many of the other
stressors associated with heat shock protein (hsp) induction. There is
evidence for other organisms that hsps are developmentally regulated.
Therefore, we examined whether hsp induction is an early event in
bradyzoite differentiation. Extracellular and intracellular T. gondii cells, after exposure to pH 8.1 or 7.1, were analyzed for
the expression of inducible hsp70 by using monoclonal antibody C92F3A-5
(specific to hsp70). Western blotting demonstrated that a 72-kDa
protein reactive with C92F3A-5 (hsp70), which we believe is part of the hsp70 family, is induced during bradyzoite development. By
immunofluorescence and immunoelectron microscopy, we were able to
demonstrate that hsp70 staining colocalized to T. gondii
expressing bradyzoite-specific antigens and the presence of hsp70 in
bradyzoites isolated from mouse brain. Quercetin, a bioflavonoid which
inhibits the synthesis of hsp90, hsp70, and hsp27, suppresses the
induction of bradyzoite development in vitro. Reverse transcription-PCR
with conserved hsp70 primers demonstrated an increase in hsp70 in
T. gondii on exposure to conditions which induce bradyzoite
formation. A T. gondii hsp70 was subsequently cloned and
sequenced by using this amplified fragment. We believe our evidence
suggests that hsps are important in the process of bradyzoite
differentiation.
Toxoplasma gondii is a
well-described ubiquitous Apicomplexan protozoan parasite of mammals
and birds. It has long been recognized as an important opportunistic
pathogen of immunocompromised hosts and is a major opportunistic
pathogen of the AIDS epidemic (23, 43). Although
overwhelming disseminated toxoplasmosis has been reported, the
predilection of this parasite for the central nervous system, causing
necrotizing encephalitis, constitutes its major threat to patients with
human immunodeficiency virus infection (AIDS).
The development of Toxoplasma encephalitis is believed to be
due to the transition of the resting, or bradyzoite, stage to the
active and rapidly replicating tachyzoite form (11, 17). Although these stages are well defined morphologically, little is known
about how interconversion from one to the other stage occurs or what
signal(s) mediates this transformation. Several studies have
demonstrated that bradyzoites can develop in vitro and that the
development of cyst-like structures can be demonstrated by transmission
electron microscopy (TEM) (16, 21, 22, 26, 35) and more
recently by bradyzoite-specific monoclonal antibodies (MAbs) (4,
37, 40). Feeding experiments with cats have demonstrated that
tissue culture-derived cysts are biologically identical to cysts
obtained from animal tissues (15, 21). In addition, both
animal- and tissue culture-derived bradyzoites are pepsin resistant.
The factors affecting the transition of bradyzoites to tachyzoites
remain to be defined. In tissue culture studies, it is evident that
bradyzoites spontaneously convert to tachyzoites and that tachyzoites
spontaneously convert to bradyzoites. The rate of conversion appears to
be strain dependent. Thus, low-virulence strains, i.e. strains that
form high numbers of cysts in mice, such as ME49, have a higher
spontaneous rate of cyst formation in culture than do virulent strains
such as RH (36). The rate of replication of tachyzoites,
which is greater than that of bradyzoites, enables tachyzoites to
destroy the cell monolayer, thereby obscuring bradyzoite formation.
Inhibiting the rapid growth of tachyzoites, either by drugs
(pyrimethamine [5]), cytokines (gamma interferon [5, 36, 40]), or frequent removal (26),
gradually increases the percentage of bradyzoites in culture,
consistent with their lower replication rate. However, these conditions
do not induce an increase in the rate of switching of tachyzoites to
bradyzoites but rather prevent destruction of the monolayer by
tachyzoites and thereby permit normal bradyzoite development.
We and others have previously observed that stress conditions were
associated with the induction of bradyzoite development; i.e., there
were more bradyzoites under these conditions than would be expected
from simple inhibition of tachyzoite replication. It was found that
temperature (43°C [36]), pH (pH 6.8 or 8.2 [36, 40]), or chemical (sodium arsenite
[36]) stress resulted in an increase in bradyzoite
antigen expression by T. gondii in culture and an increase
in the observed number of cyst-like structures. In murine macrophage
lines derived from bone marrow, gamma interferon increased bradyzoite
antigen expression, which appeared to be related to nitric oxide (NO)
induction (5). Similarly, when Toxoplasma was
grown in host cells with a nonfunctional mitochondrial respiratory
chain, both oligomycin (an inhibitor of mitochondrial ATP synthetase
function) and antimycin A (an inhibitor of the electron transport of
the respiratory chain) (5, 38) increased bradyzoite antigen
expression, although not to the same extent as NO (5).
Heat shock- or stress-induced activation of a set of heat shock protein
(hsp) genes, is characteristic of almost all eukaryotic and prokaryotic
cells. The hsps fall into several subfamilies, namely, the
low-molecular-mass hsps (16 to 35 kDa), the hsp60 family, the hsp70
family (68 to 78 kDa), and the high-molecular-mass hsps (89 to 110 kDa)
(27). Heat exposure, chemical agents (sodium arsenite),
mitochondrial inhibition (2,4-dinitrophenol, sodium azide, and other
uncouplers of oxidative phosphorylation), transition series metals,
hydrogen peroxide, and anaerobic conditions are all associated with the
induction of hsps (27). Many of these agents are associated
with bradyzoite induction in vitro (5, 36, 39). In many
other organisms, small hsps are developmentally regulated (13,
14).
We have recently identified and cloned the bradyzoite gene
BAG5, identified by the bradyzoite-specific monoclonal
antibody 74.1.8 (29), and determined that its product is
related to the small hsps (29). This antigen was also
identified by another group and designated BAG1/hsp30 (6).
It is highly represented in the bradyzoite-specific dBEST database
(http://daphne.humgen.upenn.edu:1024/toxodb/ver_2/toxodb.html), representing at least 3% of all clones identified. In addition to the small hsps, members of the hsp70 family have been associated with differentiation in several organisms, and we therefore examined whether hsp70 induction was associated with bradyzoite formation in
T. gondii. We found that hsp70 expression was associated
with bradyzoite differentiation and subsequently cloned a T. gondii hsp70 homolog.
T. gondii isolation and culture.
Cysts were
obtained from BALB/cDM1 mice at 30 days postinfection with
T. gondii ME49 and purified by isopycnic centrifugation (40). After rupture of the cysts with trypsin, 1,000 to
2,000 bradyzoites were added to a flask of 50% confluent human
fibroblasts (ATCC CRL 1475 [CCD-27SK]), and subsequently 1,000 to
5,000 tissue culture-derived T. gondii organisms, up to
passage 20, were used to inoculate a new fibroblast monolayer.
Dulbecco's modified Eagle's medium supplemented with 10% fetal calf
serum (Gibco-BRL, Gaithersburg, Md.), 10 mM HEPES (pH 6.8, 7.1, or 8.1)
and 1% penicillin-streptomycin was replaced weekly. Fibroblasts were
subcultured weekly with 0.25% trypsin-0.03% EDTA at a subcultivation
ratio of 1:4 and used between passages 6 and 30. T. gondii
RH was maintained by twice-weekly passage in human fibroblasts.
Bradyzoite in vitro assay.
We previously demonstrated by
immunofluorescence, TEM, and Western blotting the in vitro development
of bradyzoites and development of cysts together with tachyzoites in
continuous cell cultures of human fibroblasts (40). Five
thousand parasites were used to infect a fibroblast monolayer in a
two-chamber culture slide (Permanox; Nalge-Nunc, Naperville, Ill.), or
10,000 parasites were used in a T25 flask. At the time of infection,
pH-adjusted medium containing the drugs of interest was added. At 3 days postinfection, the slides were washed in phosphate-buffered
saline, fixed for 30 min with 2% buffered formalin, permeabilized with
0.2% Triton X-100 for 20 min, and blocked with 1% bovine serum
albumin overnight. They were then incubated with the primary
antibody(ies) at the appropriate dilution for 90 min at 37°C, washed,
incubated with the secondary antibody (rhodamine [RHOD]-conjugated
anti-mouse immunoglobulin G [IgG] at 1:75 or RHOD-conjugated
anti-rabbit IgG or fluorescein isothiocyanate-conjugated anti-rabbit
IgG at 1:200) (Southern Biotechnology, Birmingham, Ala.), overlaid with 2.5% DABCO (1,4-diazabicyclo-[2,2,2]octane)-phosphate-buffered saline, and examined with a Nikon Diaphot inverted fluorescence microscope. For dual-antibody staining on the same slide,
RHOD-conjugated anti-mouse IgG and fluorescein
isothiocyanate-conjugated anti-rabbit IgG were utilized together. The
total number of bradyzoite antibody-positive Toxoplasma
vacuoles was determined, as was the total number of Toxoplasma vacuoles for each specimen.
hsp antibody.
C92F3A-5, a MAb specific to the inducible form
of hsp70 (SPA810; StressGen, Victoria, British Columbia, Canada), was
used at 1:100 to 1:200 for immunofluorescence and at 1:1,000 for
Western blotting. C92F3A-5 does not react with cognate hsp70 (hsc70).
Toxoplasma antibodies.
MAb 74.1.8 (IgG2b,
bradyzoite specific, reactive to the 28-kDa antigen BAG1/hsp30
[BAG5]) (41) was used at a 1:50 dilution, polyclonal
rabbit anti-recombinant BAG1/hsp30 (BAG5) (25, 29) was used
at 1:500, polyclonal rabbit anti-recombinant MAG1 (30) (a
gift of S. Parmley, Palo Alto Medical Foundation, Palo Alto, Calif.)
was used at 1:250, MAb DG52 (IgG2a, tachyzoite specific, reactive to
SAG-1 [p30]) (a gift of J. Boothroyd, Stanford University) was used
at a 1:500 dilution, and MAb 92-10B (IgG1, reactive to GRA-1 found in
both stages) was used at a 1:100 to 1:200 dilution for
immunofluorescence.
Chemicals.
Indomethacin (Sigma, St. Louis, Mo.) was
dissolved in ethanol at 25 mg/ml, and quercetin (Sigma) was dissolved
in dimethyl sulfoxide (DMSO) at 25 mg/ml. Drugs were diluted in medium
to the required concentrations prior to use. DMSO or ethanol was added
in similar concentrations to control slides. DMSO and ethanol had no
effect on bradyzoite formation at the concentrations used. Sodium
nitroprusside (SNP) was used as a nitric oxide (NO) donor; a stock
solution of 10 mg/ml in distilled water was diluted in medium prior to
use.
Western blotting.
Samples of cell culture supernatant
containing free organisms, organisms purified from human fibroblasts by
rupture with a 27-gauge needle followed by filtration through a 3.0 µm-pore-size Nuclepore filter, or T. gondii-infected human
fibroblast monolayers were split into equal samples which were then
assayed for protein concentration (Bio-Rad, Hercules, Calif.) and
dissolved in gel sample buffer (40). Equal amounts of
protein and/or organisms (determined by counting of extracellular
organisms in a hemocytometer) were loaded onto sodium dodecyl sulfate
(SDS)-polyacrylamide gels, electrophoresed, and transferred to
nitrocellulose as previously described (40). The amount of
bradyzoite-specific antigen was ascertained by Western blotting as
previously described with MAb 74.1.8 (29), and hsp70
reactivity was determined with a 1:1,000 dilution of C92F3A-5.
Detection of bound antibody was performed by using the Western Light
Kit (Tropix Inc., Bedford, Mass.), employing chemiluminescence with
disodium
3-{4-methoxyspiro[1,2-dioxetane-3,2'-(5'chloro)tricyclo(3.3.1.1) decan]-4-yl}phenyl phosphate (CSPD) and an alkaline
phosphatase-labeled secondary anti-mouse IgG antibody (1:10,000
dilution). Gel analysis and densitometry were performed on bands by
using Sigma Gel (version 1.05) (Jandel Scientific Software, SanRafael,
Calif.).
PCR.
Degenerate primers for the amplification of hsp70 were
designed based on the amino acid sequence corresponding to published gene alignments for hsp70 (7). The hsp70 primer set (numbers correspond to amino acid positions, and I is inosine) was hsp70-158f (5'-CCIGCITA[T/C]TT[T/C]AA[T/C]GA-3') and hsp70-385r
(5'-GCIACIGC[T/C]TC[A/G]TCIGG-3'). As a control, a primer set for
the
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bradyzoite Development in Toxoplasma
gondii and the hsp70 Stress Response
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-tubulin gene of T. gondii was utilized
(29): Tub2F (5'-CCAGCGTCTGTGACATCC-3') and Tub2R (5'-CCCATCTCGCCCTCTT-3').
Cloning of the hsp70 gene of T. gondii.
Dilutions of a
T. gondii RH cDNA library in
ZAP (a gift of J. Ajioka)
were incubated with Escherichia coli XL1-Blue MRF', plated
in top agar (0.8% agar in Luria-Bertani broth) on Luria-Bertani plates, and incubated for 42°C for 18 h. Plates containing
plaques were overlaid with a nitrocellulose membrane, the membrane was lifted after 5 min, and membrane-bound DNA was then denatured with 0.5 N NaOH-1.5 M NaCl, neutralized with 1 M Tris-HCl (pH 7.5)-1.5 M NaCl
treatment, and UV cross-linked by using 0.600 J/cm2 in a UV
Translink (ISS, Natick, Mass.) (3). Nitrocellulose membranes
were then prehybridized in DIG Easy Hyb (Boehringer Mannheim,
Indianapolis, Ind.) for 3 h at 42°C and hybridized in DIG Easy
Hyb containing 7.5 ng heat-denatured digoxigenin random primer-labeled
TgHSPB3 insert (High Prime Digoxigen DNA labeling kit; Boehringer
Mannheim) per ml for 6 h. The membranes were then washed twice for
5 min each at 25°C with 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate)-0.1% SDS and once for 15 min at 68°C with 0.1×
SSC-0.1% SDS. Membranes were then incubated for 5 min in maleic acid
buffer (100 mM maleic acid, 150 mM NaCl, pH 7.5) containing 3%
(vol/vol) Tween 20 and blocked for 2 h in maleic acid buffer
containing 1% blocking reagent (Boehringer Mannheim). The membranes
were then incubated with a 1:5,000 dilution of alkaline
phosphatase-conjugated anti-digoxigenin antibody (Boehringer Mannheim)
in the blocking solution for 30 min and washed twice for 15 min each in
maleic acid buffer containing 3% (vol/vol) Tween 20, and reactive
plaques were detected with nitroblue
tetrazolium-5-bromo-4-chloro-3-indolylphosphate (NBT-BCIP) in 100 mM
Tris-HCl-100 mM NaCl (pH 9.5) over 2 h. Five clones (C1-1, C1-2,
C1-3, C1-4, and C3) were identified and subsequently plaque purified.
Clones were excised from the
ZAP phage as an ampicillin-resistant
pBS phagemid vector by using the ExAssist interference-resistant helper
phage and E. coli XLOLR (
ZAP cloning kit; Stratagene, La
Jolla, Calif.). Plasmid DNA was subsequently purified by using Wizard
Plus (Promega).
Electron microscopy. Cultures were fixed in 2.5% (vol/vol) glutaraldehyde-0.1 M sodium cacodylate (pH 7.2) in 1% paraformaldehyde, dehydrated in graded ethanol solutions, and embedded in LR White. Sections were placed on 300-mesh nickel grids coated with Formvar and carbon. Grids were incubated in blocking buffer (1% bovine serum albumin fraction V [Sigma] and 0.02% sodium azide in phosphate-buffered saline [pH 7.35] with 5% goat serum) at 4°C for 12 h and then incubated with a 1:5 dilution of antibody in ascites for 2 h at 20°C and then with a 1:20 dilution of goat anti-mouse IgG conjugated with 12-nm colloidal gold (Jackson ImmunoResearch, West Grove, Pa.) at 20°C for 90 min. Grids were stained with 1% uranyl acetate for 45 min and examined by TEM.
Statistics. All conditions were repeated on two slides (four chambers) for each experiment, and all experiments were repeated three times. Thus, six replications of each experimental condition were performed. Data were expressed as the fold stimulation versus the control (no drug, pH 7.1) and/or as the total number of bradyzoite antigen-positive vacuoles (i.e., cysts) and were analyzed by nonparametric (Wilcoxon signed-rank test) and/or parametric (Student t test) methods. Thus, if the experimental condition resulted in no change from the control, the fold stimulation would be 1.0, and if it doubled the number of organisms expressing bradyzoite antigens, the fold stimulation would be 2.0. The standard error of the mean for calculated fold stimulations was less than 7%.
Nucleotide sequence accession number. The sequence data in this paper have been submitted to GenBank (accession no. AF045559).
| |
RESULTS |
|---|
|
|
|---|
In order to separate the effects of stress conditions known to induce bradyzoite formation directly on the parasite from the effects of these conditions on both host cells and parasites, we evaluated whether a relatively brief exposure (i.e., 1 h) of extracellular T. gondii tachyzoites to various conditions would induce bradyzoite formation. When extracellular T. gondii organisms were incubated in pH 8.1 medium for 1 h before they were used to infect a fibroblast monolayer at pH 7.1, there was a significant increase in bradyzoite antigen expression at 48 h compared to when extracellular T. gondii organisms were incubated at pH 7.1 prior to infection. After pH 7.1 exposure, there were 297 ± 63 cysts/flask, and after pH 8.1 exposure, there were 877 ± 100 cysts/flask, a 2.5- to 3-fold induction in cyst number (which was a 2-fold increase in the percentage of vacuoles expressing bradyzoite antigens). SNP, an NO donor, is a strong inducer of bradyzoite development (5). After 3 days in culture with 100 µM SNP, 80% of all vacuoles expressed bradyzoite antigens, and there was a threefold increase in the total number as well as the percentage of organisms expressing bradyzoite antigens. Pretreatment of human fibroblasts with pH 8.1 medium or SNP followed by removal of these agents prior to infection with T. gondii at pH 7.1 did not affect bradyzoite formation. After a 1-h exposure of extracellular organisms to 100 µM SNP followed by culture at pH 7.1 without SNP, we observed a 1.5- to 2-fold increase in the total number as well as percentage of organisms expressing bradyzoite antigens (40% without SNP exposure and 80% after SNP exposure). Thus, short-term exposure of extracellular tachyzoites to inducing conditions should facilitate the study of early genes in bradyzoite development which may act as triggers for stage conversion.
Given the association of the induction of bradyzoite development in vitro with temperature, pH, mitochondrial inhibitors, sodium arsenite, and many of the other stressors associated with hsp induction, we sought evidence that such induction is an early event in bradyzoite development. Therefore, we examined extracellular T. gondii after a 1-h exposure to pH 8.1 versus pH 7.1 for the expression of inducible hsp70. This protocol allowed examination of the parasitic hsps without significant contamination by host cell proteins. For detection by Western blotting, we utilized MAb C92F3A-5 (StressGen), which is specific to the inducible form of hsp70. As can be seen from Fig. 1, an hsp70 is induced at 1 h in ME49 exposed to pH 8.1 medium as compared to that incubated with pH 7.1 medium, demonstrating that a presumptive hsp is induced by the pretreatment protocol that also induced bradyzoite formation (equal numbers of organisms were loaded in each lane).
|
In order to demonstrate that the T. gondii hsp was also induced in intracellular parasites, we took advantage of the observation that the antigen recognized by C92F3A-5 in T. gondii ME49 was 72 kDa in size and the fact that in human fibroblasts this antibody recognizes a 70-kDa protein. We therefore examined by Western blotting intracellular T. gondii ME49 that had been subjected to pH 8.1 or 7.1 treatment prior to infection. At day 3 postinfection the infected fibroblast monolayer was harvested, and the proteins were resolved by SDS-polyacrylamide gel electrophoresis followed by Western blotting with MAb C92F3A-5. As can be seen in Fig. 1, there is a 72-kDa band specific to T. gondii above the human 70-kDa hsp band in T. gondii-infected cultures at pH 7.1 and 8.1, and this band is not seen in human fibroblasts without infection. By densitometry this antigen was found to be increased fourfold in pH 8.1-treated T. gondii compared to the amount seen in pH 7.1-treated cells. A recombinant human hsp70 was included as a positive control. A similar increase in hsp70 was demonstrated when T. gondii was purified from the human fibroblast monolayer prior to electrophoresis (data not shown).
By using degenerate primers to conserved regions of hsp70, an amplicon
of
680 bp (Fig. 2) corresponding to
the predicted size based on homology with other hsp70 genes was
demonstrated in T. gondii. Sequencing of this amplicon (Fig.
3, positions 582 to 1257) and analysis by
using the National Center for Biotechnology Information Blastx program
(http://www.ncbi.nlm.nih.gov/BLAST/) (12) was performed.
This gene fragment had high-level homology (Blast score of >500) to
the following genes, all of which were from Apicomplexan parasites:
Eimeria acervulina hsp (accession no. Z26134), Eimeria
maxima hsp70 (cytosolic) (Z46964), Plasmodium cynomolgi
hsp70 (cytoplasmic) (M90978), Plasmodium falciparum hsp70
(cytoplasmic) (M19753), and Cryptosporidium parvum hsp70
(U71161 and U11781). This suggests that the amplicon is an inducible
hsp70 from T. gondii. By RT-PCR this presumptive hsp70
appeared to be increased by exposure of T. gondii to pH 8.1 (Fig. 2). Standardizing the amount of hsp70 amplicon on the gel to the
amount of
-tubulin mRNA amplicon detected by RT-PCR gives a three-
to fourfold induction of hsp70 in extracellular T. gondii
tachyzoites exposed to pH 8.1 medium for 1 h. When strain RH
tachyzoites were used, no increase in hsp70 was seen by RT-PCR, and no
increase in the bradyzoite antigen BAG1/hsp30 (BAG5), which is reactive
with MAb 74.1.8, could be demonstrated by immunofluorescence or Western
blotting following pH 8.1 or SNP treatment (data not shown).
|
|
The hsp70 amplicon was used to identify corresponding cDNA clones from
a
ZAP library. Two of the clones, C1-1 and C3, containing inserts of
about 2,500 bp were sequenced in both directions. The resultant
2,382-bp sequence (Fig. 3) had an open reading frame encoding 667 amino
acids with a predicted molecular mass of 72,330 Da. The predicted
sequence has a repetitive GGMP motif toward the carboxy-terminal
portion of the protein, which is seen in other Apicomplexan hsp70 genes
(10). Analysis of this sequence with the Blastx program
(http://www.ncbi.nlm.nih.gov/BLAST/) (12) was performed and
identified this protein as belonging to the inducible hsp70 group. It
had the highest homology (Blast scores of over 500) to other
Apicomplexan hsp70 genes as described above for the hsp70 gene
fragment. This T. gondii hsp70 gene had 89.2% similarity to
the E. acervulina hsp70 gene (accession no. Z26134) and only
73.2% similarity to the human hsp70 gene. Northern analysis of
T. gondii mRNA demonstrated a single band of about 2.3 kb
(data not shown). Southern blotting of T. gondii genomic DNA
cut with EcoRI, PstI, BamHI,
EcoRV, HindIII, SacI, or
XbaI and probed with clone C1-1 (T. gondii hsp70)
demonstrated a pattern consistent with this T. gondii hsp70
gene being a single-copy gene (data not shown).
Utilizing immunofluorescence with MAb C92F3A-5 on human fibroblasts infected with T. gondii ME49 that had been treated at pH 8.1, we were able to demonstrate that hsp70 staining was localized most strongly to T. gondii expressing bradyzoite-specific antigens (Fig. 4A and B). Little to no staining was observed in tachyzoites (Fig. 4A and D). Similarly, by immunoelectron microscopy, we were able to demonstrate reactivity of MAb C92F3A-5 with bradyzoites isolated from mouse brain and from tissue culture (Fig. 5A and B). Thus, we believe that hsp70 expression is associated with the development of bradyzoites.
|
|
Quercetin, a bioflavonoid, has been reported to inhibit the synthesis of many hsps, including hsp90, hsp70, and hsp27, while having no effect on the synthesis of other cellular proteins (9). Quercetin at 100 µM inhibited the pH 8.1-associated induction of bradyzoite antigens (Table 1) (1.8- and 1.1-fold increases in the percentages of bradyzoite antigen-positive vacuoles for control and quercetin treatments, respectively). In addition, the total number of bradyzoite antigen-positive vacuoles was lower in the presence of quercetin at either pH 7.1 or 8.1 (control, 86 ± 9 cysts/slide at pH 7.1 and 142 ± 9 cysts/slide at pH 8.1; quercetin [100 µM], 56 ± 2 cysts/slide at pH 7.1 and 59 ± 4 cysts/slide at pH 8.1). Quercetin was also found to decrease the growth of T. gondii (at 100 µM there was a 30 to 40% decrease in the total number of vacuoles compared to that with the control (214 ± 10 versus 147 ± 5). Thus, at pH 8.1, in the absence of quercetin 60% of organisms expressed bradyzoite antigens and in the presence of quercetin only 39% expressed bradyzoite antigens. Quercetin also decreased the expression of hsp70 in pH 8.1-treated T. gondii ME49 as ascertained by immunoblotting with MAb C92F3A-5 (Fig. 6). The induction of bradyzoites due to SNP was also inhibited by quercetin (Table 1). To our knowledge, quercetin is the first compound that has been reported to decrease bradyzoite formation.
|
|
Nonsteroidal antiinflammatory drugs have been reported to induce hsps through effects on heat shock transcription factors (20). Treatment of cells with indomethacin has been associated with a decrease in the temperature required to obtain a heat shock response, i.e., a synergistic interaction resulting in a decrease in the heat shock threshold and protection of cells against cytotoxic conditions (20). Thus, we examined the effects of indomethacin on bradyzoite antigen expression (Table 1). In the presence of 100 µg of indomethacin per ml, a 1.6-fold increase in bradyzoite antigen-positive organisms was seen at pH 7.1 and a 3.0-fold increase was seen at pH 8.1, compared to values for controls (no indomethacin) at pH 7.1. At pH 8.1 without indomethacin, there was a 1.6-fold increase in bradyzoite antigen-positive organisms compared to that at pH 7.1. Immunoblotting with MAb 92F3A-5 demonstrated an increase in hsp70 in indomethacin-treated T. gondii (Fig. 6). Indomethacin thus appeared to facilitate the development of bradyzoites and may have been synergistic with pH shock.
| |
DISCUSSION |
|---|
|
|
|---|
The data presented indicate that hsps play a role in bradyzoite differentiation. For example, quercetin, a bioflavonoid which inhibits the synthesis of hsp90, hsp70, and hsp27, suppressed the induction of bradyzoite development in vitro. Indomethacin, which increases hsp expression, was associated with an increase in bradyzoite formation. An inducible hsp70 homolog was demonstrated in bradyzoites by Western blotting, immunoelectron microscopy, and immunofluorescence with MAb C92F3A-5. This MAb was reported to react with inducible hsp70s.
Finally, RT-PCR with degenerate primers to conserved regions of hsp70 demonstrated the presence of an hsp70 homolog in T. gondii on exposure to conditions which induce bradyzoite formation. This hsp70 amplicon was subsequently utilized to clone a T. gondii hsp70 gene. The identified T. gondii hsp70 gene is a single copy gene. In other Apicomplexa, such as P. cynomolgi, the hsp70 gene is also present as a single copy in the genome. An hsp70 gene has been mapped to chromosome V of T. gondii by using an hsp70 gene of Trypanosoma brucei as a probe (34). Using a polyclonal antiserum to P. falciparum hsp70, Lyons and Johnson (24) were able to demonstrate an increase in hsp70 in T. gondii RH during in vivo infection. This protein was not observed in vitro by using standard culture techniques (pH 7.1). This suggests that the stress experienced by the parasite during the infection (i.e., the immune response of the host) induced hsp70 gene expression in the parasite (24). The three- to fourfold change in hsp70 levels in T. gondii seen with stress as well as differentiation in our current study are consistent with the magnitude of the hsp70 response demonstrated for other Apicomplexa, such as Theileria annulata (33).
Both SNP and pH 8.1 treatment have been previously reported to induce bradyzoite differentiation (5, 36, 40) in vitro. We have demonstrated that differentiation in this parasite can be triggered by a brief (1-h) exposure of extracellular T. gondii to these agents. This suggested that much of the effect of these inducing agents is directly on the parasite rather than due to effects of these agents on the host cells. In our experience this effect is most easily demonstrated with T. gondii strains such as ME49 or PLK (a clonal derivative of ME49).
It has become clear that hsps are not limited to stress responses but are developmentally regulated as well. The heat shock response of fungi such as Saccharomyces cerevisiae and Neurospora crassa has been extensively studied, and the pattern of hsps induced varies with fungal development (2, 13, 19). For example, expression of hsp34 and hsp38 is induced during fungal development (19). The transition from vegetative growth to differentiation resulted in production of mRNAs encoding hsps (2). Our group (29) as well as Bohne et al. (6) have identified a bradyzoite-specific antigen in T. gondii, BAG1/hsp30 (BAG5), that has homology to small hsps. Given recent data on the presence of plant-like structures in T. gondii (18, 38), it is interesting that BAG1/hsp30 (BAG5) displays its highest homology at the carboxy terminus to a number of small hsps of plants with molecular sizes of 17 to 22 kDa. In many plants, differentiation events, such as seed formation, are associated with the induction of small hsps (13, 27). In invertebrates, mammals, and birds the small hsps have been associated with differentiation. In Drosophila, for example, hsp27, hsp26, hsp23, and hsp22 are expressed in a tissue-specific manner during development and appear to have key functions in development (1).
Members of the hsp70 family have also been associated with differentiation in many different organisms. In Blatocladiella emersonii, hsp70 expression is induced during sporulation, and hsp70 has been associated with hyphal branching and secretion in response to steroids in Achlya ambisexualis (13). For Histoplasma capsulatum, mitochondrial ATPase activity and hsp70 induction have been correlated with the transition from mycelium to yeast phase (31). For protozoa such as Leishmania chagasi (42) and Trypanosmoa cruzi (32), hsp70 has been associated with the capacity to survive oxidant stress and may also play a role in the differentiation of promastigotes to amastigotes. For P. cynomolgi, hsp70 expression has been associated with the asexual stages (10). In addition to affecting gene expression, the heat shock responses have been associated with changes in cellular metabolism in Xenopus, including interruption of oxidative phosphorylation leading to anaerobic glycolysis (13, 28). In this regard, it is interesting that bradyzoites may depend on such glycolytic pathways more than the tachyzoite stage for energy metabolism, due to the absence of a functional tricarboxylic acid cycle (8) as well as the presence of developmentally regulated lactate dehydrogenase genes (44).
During the process of differentiation, multiple genes are expressed and structural remodeling of T. gondii occurs. The process of differentiation probably depends on the ratio of regulatory factors (growth) to DNA templates (division) over time (33). Heat shock proteins are clearly induced during these events. They may function as chaperones, like hsp70, or have as-yet-unknown functions, like the small hsps. Knockout mutations of hsps in T. gondii may shed light on the interactions of hsps and their involvement in the process of stage transitions (tachyzoite to bradyzoite and bradyzoite to tachyzoite). In addition, study of the factors regulating this stress response may yield information on the regulation of the process of transformation of tachyzoites to bradyzoites. We hypothesize that the process of bradyzoite differentiation in T. gondii is a stress response triggered by environmental conditions related to the inflammatory process in the host and that the heat shock response is related to the metabolic adaptations in this parasite during differentiation.
| |
ACKNOWLEDGMENTS |
|---|
We acknowledge Denise LaPlace for her technical assistance.
This work was supported by Public Health Service grant AI39454 from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Albert Einstein College of Medicine, 1300 Morris Park Ave., Room 504 Forchheimer, Bronx, NY 10461. Phone: (718) 430-2142. Fax: (718) 430-8543. E-mail: lmweiss{at}aecom.yu.edu.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arrigo, A. P., and R. M. Tanguay. 1991. Expression of heat shock proteins during development in Drosophila., p. 106-119. In L. Hightower, and L. Nover (ed.), Heat shock and development. Springer-Verlag, Berlin, Germany. |
| 2. | Atkinson, B. G., M. Raizada, F. A. Bouchard, J. R. H. Frappier, and D. B. Walden. 1993. The independent stage-specific expression of the 18 kDa heat shock protein genes during microsporogenesis in Zea mays. Dev. Genet. 14:15-26[Medline]. |
| 3. | Ausubel, F., R. Brent, R. E. Kingston, P. Moore, J. Seidman, J. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology. Wiley Interscience, New York, N.Y. |
| 4. |
Bohne, W.,
J. Hessemann, and U. Gross.
1993.
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages.
Infect. Immun.
61:1141-1145 |
| 5. |
Bohne, W.,
J. Hessemann, and U. Gross.
1994.
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.
Infect. Immun.
62:1761-1767 |
| 6. | Bohne, W., U. Gross, D. J. Ferguson, and J. Heesemann. 1995. Cloning and expression of a bradyzoite specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat shock proteins of plants. Mol. Microbiol. 16:1221-1230[Medline]. |
| 7. | Boorstein, W. R., T. Siegelhoffer, and E. A. Craig. 1994. Molecular evolution of the HSP70 multigene family. J. Mol. Evol. 38:1-17[Medline]. |
| 8. | Denton, H., C. W. Roberts, J. Alexander, K. W. Thong, and G. H. Coombs. 1996. Enzymes of energy metabolism in the bradyzoites and tachyzoites of Toxoplasma gondii. FEMS Microbiol. Lett. 137:103-108[Medline]. |
| 9. | Doishi, M., N. Hosokawa, M. Sato, A. Nakai, K. Hirayoshi, M. Hiraoka, M. Abe, and K. Nagata. 1992. Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line. Jpn. J. Cancer Res. 83:1216-1222[Medline]. |
| 10. | Eckert, V., L. Sanchez, A. Cochrane, and V. Enea. 1992. Plasmodium cynomolgi: the hsp70 gene. Exp. Parasitol. 75:323-328[Medline]. |
| 11. | Frenkel, J. K., and A. Escajadillo. 1987. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. Am. J. Trop. Med. Hyg. 36:517-522. |
| 12. | Gish, W., and D. J. States. 1993. Identification of protein coding regions by database similarity search. Nat. Genet. 3:266-272[Medline]. |
| 13. | Heikkila, J. J. 1993. Heat shock gene expression and development. I. An overview of fungal, plant, and poikilothermic animal developmental systems. Dev. Genet. 14:1-5[Medline]. |
| 14. | Heikkila, J. J. 1993. Heat shock gene expression and development. II. An overview of mammalian and avian developmental systems. Dev. Genet. 14:87-91[Medline]. |
| 15. | Hoff, R. L., J. P. Dubey, A. M. Behbehani, and J. K. Frenkel. 1977. Toxoplasma gondii cysts in cell culture: new biologic evidence. J. Parasitol. 63:1121-1124[Medline]. |
| 16. |
Jones, T. C.,
K. A. Bienz, and P. Erb.
1986.
In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon.
Infect. Immun.
51:147-156 |
| 17. | Kasper, L., and J. C. Boothroyd. 1993. Toxoplasma gondii and toxoplasmosis, p. 269-301. In K. Warren (ed.), Immunology and molecular biology of parasitic infections. Blackwell Scientific Publications, Boston, Mass. |
| 18. |
Kohler, S.,
C. F. Delwiche,
P. W. Denny,
L. G. Tilney,
P. Webster,
R. J. Wilson,
J. D. Palmer, and D. S. Roos.
1997.
A plastid of probable green algal origin in Apicomplexan parasites.
Science
275:1485-1489 |
| 19. |
Kurtz, S., and S. Lindquist.
1984.
Changing patterns of gene expression during sporulation in yeast.
Proc. Natl. Acad. Sci. USA
81:7323-7327 |
| 20. |
Lee, B. S.,
J. Chen,
C. Angelidis,
D. Jurivich, and R. I. Morimoto.
1995.
Pharmacologic modulation of heat shock factor 1 by drugs results in protection against stress-induced cellular damage.
Proc. Natl. Acad. Sci. USA
92:7207-7211 |
| 21. | Lindsay, D. S., J. P. Dubey, B. L. Blagburn, and M. A. Tovio-Kinnucan. 1991. Examination of tissue cyst formation by Toxoplasma gondii in cell cultures using bradyzoites, tachyzoites and sporozoites. J. Parasitol. 77:126-132[Medline]. |
| 22. | Lindsay, D. S., M. A. Tovio-Kinnucan, and B. L. Blagburn. 1993. Ultrastructural determination of cystogenesis by various Toxoplasma gondii isolates in cell culture. J. Parasitol. 79:289-292[Medline]. |
| 23. | Luft, B. J., and J. S. Remington. 1988. Toxoplasma encephalitis. J. Infect. Dis. 157:1-6[Medline]. |
| 24. | Lyons, R. E., and A. M. Johnson. 1995. Heat shock proteins of Toxoplasma gondii. Parasite Immunol. 17:353-359[Medline]. |
| 25. | McAllister, M. M., S. F. Parmley, L. M. Weiss, V. J. Welch, and A. M. McGuire. 1996. An immunohistochemical method for detecting bradyzoite antigen (BAG5) in Toxoplasma gondii-infected tissues cross-reacts with a Neospora caninum bradyzoite antigen. J. Parasitol. 82:354-355[Medline]. |
| 26. | McHugh, T. D., A. Gbewonyo, J. D. Johnson, R. E. Holliman, and P. D. Butcher. 1993. Development of an in vitro model of Toxoplasma gondii cyst formation. FEMS Microbiol. Lett. 114:325-332[Medline]. |
| 27. | Morimoto, R., A. Tissieres, and C. Georgophoulos. 1994. The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 28. | Nickells, R. W., and L. W. Browder. 1985. Region-specific heat shock protein synthesis correlates with a biphasic acquisition of thermotolerance in Xenopus laevis embryos. Dev. Biol. 112:391-395. |
| 29. | Parmley, S. F., L. M. Weiss, and S. Yang. 1995. Cloning of a bradyzoite-specific gene of Toxoplasma gondii encoding a cytoplasmic antigen. Mol. Biol. Parasitol. 73:253-257. |
| 30. | Parmley, S. F., S. Yang, G. Harth, L. D. Sibley, A. Sucharczuk, and J. S. Remington. 1994. Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol. Biochem. Parasitol. 66:283-296[Medline]. |
| 31. | Patriarca, E. J., G. S. Kobayashi, and B. Maresca. 1992. Mitochondrial activity and heat shock response during morphogenesis in the pathogenic fungus Histoplasma capsulatum. Biochem. Cell Biol. 70:207-214[Medline]. |
| 32. | Requena, J. M., A. Jemernes-Ruis, M. Soto, R. Assiego, J. F. Santaren, M. C. Lopez, M. E. Patarroyo, and C. Alonso. 1992. Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol. Biochem. Parasitol. 53:201-212[Medline]. |
| 33. | Shiels, B., N. Aslam, S. McKeller, A. Smyth, and J. Kinnaird. 1997. Modulation of protein synthesis relative to DNA synthesis alters the timing of differentiation in the protozoan parasite Theileria amulata. J. Cell Sci. 110:1441-1451[Abstract]. |
| 34. | Sibley, D., and J. C. Boothroyd. 1992. Construction of a molecular karyotype for Toxoplasma gondii. Mol. Biochem. Parasitol. 51:291-300[Medline]. |
| 35. | Smith, J. E., and E. K. Lewis. 1993. The growth and development of Toxoplasma gondii tissue cysts in vitro. NATO ASI ser. H. Cell Biol. 78:93-98. |
| 36. | Soete, M., D. Camus, and J. F. Dubremetz. 1994. Experimental induction of bradyzoite specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp. Parasitol. 78:361-370[Medline]. |
| 37. | Soete, M., B. Fortier, D. Camus, and J. F. Dubremetz. 1993. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp. Parasitol. 76:259-264[Medline]. |
| 38. | Tomavo, S., and J. C. Boothroyd. 1995. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii. Int. J. Parasitol. 25:1293-1299[Medline]. |
| 39. |
Tomavo, S.,
B. Fortier,
M. Soete,
C. Ansel,
D. Camus, and J. F. Dubremetz.
1991.
Characterization of bradyzoite-specific antigens of Toxoplasma gondii.
Infect. Immun.
59:3750-3753 |
| 40. | Weiss, L. M., D. LaPlace, P. M. Takvorian, H. B. Tanowitz, A. Cali, and M. Wittner. 1995. A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J. Eukaryot. Microbiol. 42:150-157[Medline]. |
| 41. | Weiss, L. M., D. LaPlace, H. B. Tanowitz, and M. Wittner. 1992. Identification of Toxoplasma gondii bradyzoite specific monoclonal antibodies. J. Infect. Dis. 166:213-215[Medline]. |
| 42. |
Wilson, M. E.,
K. A. Andersen, and B. E. Britigan.
1994.
Response of Leishmania chagasi promastigotes to oxidant stress.
Infect. Immun.
62:5133-5141 |
| 43. | Wong, S. Y., and J. S. Remington. 1993. Biology of Toxoplasma gondii. AIDS 7:299-316[Medline]. |
| 44. | Yang, S., and S. F. Parmley. 1997. Toxoplasma gondii expresses two distinct lactate dehydrogenase homologous genes during its life cycle in intermediate hosts. Gene 184:1-12[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»